nhia logo

Quick Links
Search NHIA.org


INFUSION Magazine

HOME INFUSION INDUSTRY MARKET TRENDS

Alborghetti M. New treatments revolutionize AIDS care. 1999;5(4):11-16.

Andrews D. The expanding use of IVIG: Insights into its mechanism of action. 2001 ;7(7):28-32.

Barrell JM. Infusion providers wake up to the future. 1998;4(10):37-40.

Barrell JM. Iontophoresis: Charging into drug delivery. 1999;5(9):56-58.

Barrell JM. IVIG: The next distribution battleground? 1999;6(3):35-41.

Barrell JM. Managed care: A spotlight on critical issues. 2001;7(4):28-35.

Barrell JM. Plasma-derived products: No relief in sight. 2001;7(7):34-5.

Barrell JM. Plasma therapies: How new indications, safety measures, and industry consolidation affect supply and demand. 2002;8(4):13-8.

Barrell JM. Rising to address the pharmacist shortage. 2002;8(2);16-22.

Barrell JM. Denied: Medicare TPN claims challenge cash flow, industry. 2002;8(2):20-2.

Bing CM, Bellehumeur C. Mergers and acquisitions: What to expect. 1998;4(1): 19-25.

Boesch D. The changing home infusion market: Staying ahead of the game. 1994;1(1):12-15.

Borfitz D. Snowbird in March: A report from the NHIA Executive Conference. 1997;3(8):59-64.

Borfitz D. Home care accreditation: An answer to the demands of managed care? 1998;4(5):43-46.

Borfitz D. The Joint commission: Myths and realities. 1998;4(6):33-38.

Borfitz D. Accreditation: A view from the Field. 1998;4(1):28-36.

Chielli JJ. Hospital outsourcing: Capturing contracts for infusion services. 1997;4(3):35-9.

Chielli JJ. Canada's emerging home infusion market. 1997;3(7):33-6.

Counce J. Health Care Mergers and Acquisitions Consultants Roundtable. 2008;14(5): 27-32.

Counce J. Alternate-Site IT Executive Roundtable: Infusion Pharmacy Software Company Executives Discuss Needs-Based System Design. 2008;14(4):

Counce JB. New private payer contracts: Big lessons for providers. 2002;8(6):20-5.

Counce J. Electronic success stories: Early leaders of electronic claiming reaping the benefits. 2004;10(5):16-9.

Counce J. Provider perspective: Let’s talk about AICs, 2004;10(6):20-4.

Counce J. Home infusion and specialty pharmacy: A marriage whose time has come? 2005:11(1):16-20.

Counce JB. Infusion pump sales on the rise: A look at consumer trends and possibilities. 2005. 11(4):11-16.

Counce J. Infusion’s health care index. 2006.12(6):41.

Counce J. Specialty pharmacy from pipeline to payer perspectives: NHIA executive conference explores multiple dimensions of this growing market.2007:13(3);31-4.

Counce J. Telemedicine and telehealth monitoring: Coming soon to a provider near you.2007:13(4);24-8.

Counce J. Infusion’s health care index.2008:14(1);35.

Counce J. Doing Health Care Delivery Differently: Emerging Technologies and New Health Care Models—Implications for Our Field and Beyond! 2008;14(4):26-30.

Counce J. Solving the industry-defining data puzzle—One vital piece at a time. 2013;19(3):19-20.

Counce J. New approaches, new opportunities—Modifying our efforts to strengthen NHIA's legislative, regulatory, and grassroots significance. 2013;19(3):22-25.

Counce J. NHIA board and FIAC—Relentlessly committed to fortifying the future of home and specialty infusion. 2013;19(3):26-27.

Counce J. Heightened collaboration: Magnifying our grassroots efforts to attain legislative, regulatory and advocacy objectives. 2015;21(3):22-24.

Counce J. NHIA board and FIAC: Strategically examining health care reform to amplify opportunities. 2015;21(3):32-34.

DiSalvo L, Buckner MK. Doing more with less. 1996;3(1):38-42.

Dishman E. Inventing wellness systems for aging in place.2007:13(6);23-31.

Everard LJ. Pricing out profitability. 199;5(4):28-32.

Flores K. AICs: What's your role in the most talked about delivery model? 1998;4(11):35-38.

Flores K. The nuts and bolts of ambulatory infusion centers: Start up considerations. 2004;10(6):15-9.

Franklin DM. Consolidation in health care: Living with-and through-mergers and integration. 2000;6(8):53-6.

Franklin DM. Pricing methodologies for the infusion industry. 2001;7(2):41-2.

Gaffney T and Turcotte M. Selling to the Physician Group. 2000;6(4):23-9.

Johnson K, Volkman G. Identifying and calculating activity-based pharmacy costs in home infusion and ambulatory care. 1998;4(6):15-21.

Johnson T. Treating cystic fibrosis patients in the home setting.2008:14(1);23-27.

Jurich S. A roadmap for our collective future: NHIA’s strategic plan will guide the association’s activities and advance the field. 15(5):18-20.

Jurich S. NHIA's 2012-2014 Strategic Plan—Proving the Value and Relevancy of Alternate-Site Infusion Amidst the Shifting Health Care Delivery Landscape. 2012; 18(4):32-7.

Kaplan LK. Managed care and medicare: An uneasy marriage. 1998;5(3):23-28.

Kaplan LK. Taking the long view. 1998;4(8):45-47

Kaplan LK. Crunching the numbers. 1994;1(2):29-33.

Kaplan LK. Forget the tea leaves.1998;4(9):17-22.

Kaplan LK. Looking backwards and forwards. 1995;1(4):14-19.

Kaplan LK. The infusion therapy market: Today and tomorrow. 1996;2(10):12-23.

Kaplan LK. Half empty or half full. 1997;3(4):39-44.

Kaplan LK. Ambulatory infusion centers: The talk of the town. 1997;3(10):32-36.

Kaplan LK. PBMs in home infusion. 1999;6(3):27-31.

Kaplan LK. Bayer Responds. 2000;6(4):30.

Kaplan LK. Bayer direct update: Patient advocacy groups speak out. 2000;6(7):12-4.

Kelley L. Networking for survival: There are no islands. 1998;5(3):18-22.

Lima H. Looking down the pipeline: A biotech market update. 2000;7(1):14-9.

Marrelli T. The perfect storm of a staffing shortage: A practical roadmap for coping successfully. 2003;9(6):21-5.

McKinnon BT. Biotechnology approaches the millennium-And managed care strategies keep pace. 1999;5(6):18-21.

Mohler L. Looking down the pipeline: New drugs and biologicals for 2006. 2006:12(1):21-3.

Murphy HM. It's time to step up to the plate. 1998;4(10):34-36.

McKinnon BT. Growth hormone: It's not just for kids. 1999;5(6):32-36.

McKinnon BT. Synagis®: A clinical overview. 2000;7(1):26-32.

NHIA. Managed care facts and figures. 1999;5(11):31-4.

NHIA. Bayer direct: New distribution program creates unanswered questions. 1999;6(3):16-21.

NHIA. Exclusive distribution: Hotly contested, and not sustained. 1999;6(3):22-6.

NHIA. The design and implementation of core measures for the home infusion industry.2007:13(1);21-3.

Nolet B. Outpatient parenteral antibiotic (OPAT) therapy in ambulatory infusion centers (AICs): Opportunities and management issues. 2002;8(1):26-33.

Nowobilski-Vasilios A. New drugs and biologicals 2001-2002: A review for home care practitioners. 2002;8(4):32-42.

O'Donnell KP. Home care: An industry adrift in the rough waters of managed care. 1998;4(1):12-16.

Parver A. How Others See Home Infusion—Using a code of ethics as an educational and advocacy tool. 2011; 17(2):14-15.

Richardson RJ. The infusion industry: Emerging business benchmarks. 1997;3(4):28-35.

Riddell MR. Business strategies for the new millennium: Infusion companies can benefit from becoming learning organizations. 2000;6(9):13-6.

Rigas M. Innovating Future Business Models and Relationships—Better Managing the High Cost of Biologics. 2008;14(5):17-21.

Rollins G. Touchdown! NHIA executive conference scores again. 1998:4(11):25-28.

Rollins G. Chronic care therapy: A niche with a hitch. 1998;4(12):20-24.

Rollins G. Doing well by doing good: Corporate citizenship abounds in health care companies.2008:14(2);28-34.

Saladow J. Where do we go from here? : The overall market for infusion devices continue to grow. 1998;4(9):24-39

Saladow J. Infusion device technologies: Consolidation and change. 2000;6(8):9-39.

Saladow J. Delivery device update. 2002;8(5):32-5.

Saladow J. Ambulatory infusion pump technologies: New development and how they might affect alternate site care.2007:13(4);17-22.

Salvatore T, Baxter T. Strategic planning: A primer for home infusion therapy. 1998;4(1): 39-43.

Schaffer C. Providing chronic care at home: Can we overcome the next set of hurdles? 1998;4(12):26-29.

Schumann K. Healthier babies: A valuable outcome. 2000;7(1):20-5.

Tretler M, Jurich S, and Counce J. Fortifying our future—Placing the pieced together through commitment and teamwork. 2013;19(3):12-17.

Tretler M and Counce J. Thriving amid the turbulent ride—Cultivating our courage, utilizing our experience, and fostering our creativity to generate industry opportunities. 2014;20(3):14-21.

Tretler M and Counce J. Amplifying our engagement: Home and specialty infusion community must work collectively to address the changes, risks, and opportunities emerging from evolving health care landscape. 2015;21(3):14-20.

Tretler M and Counce J. Intel's Dishman describes care in home as key to health care reform. 2015;21(3):30.

Turcotte M, Gaffney TP. Your own best advocate: You. 1998;4(12):44-46.

Vuturo GJ. 1996 National Home Infusion Association: Industry research project. 1997;3(4):19-26.

Werner K. Understanding application service providers. 2001;7(3):27-33.